Insurance Policy Comparison

#Nationwide Employer Healthcare Strategy. Self-Funded nationwide employers are facing employee health plan budget problems. Healthcare costs are running unexpectedly high. These high healthcare costs are being driven by High Cost Claimants... the 5% of health plan members with high costs that drive 50% of overall health plan spending. Here are 5 #Strategies for Employers to Lower High Claimant Healthcare Costs: 1) #Network: Switch carriers to the only 1 out of the 4 major insurance carriers that has decent contracts with major hospital systems. 2) #ClaimsData: Get your claims data including allowed amount (and preferably Billed Charges, Provider NPI number and Provider Tax ID Number). Put your carrier out for RFP if necessary and include this data requirement in your RFP. 3) Engage #HighCost Claimants: Use the claims data to identify and assist existing high cost claimants and predict and prevent the most probable future high cost claimants. Use age greater than 50 as an initial screen for these potential high cost claimants. 4) Address Fraud, Waste and Abuse (#FWA): Use your claims data to identify fraudulent claims and prevent future payments to that same provider equal to the amount of the fraud. 5) #PBM: Carve-out your PBM to a transparent, pass-through PBM that DOES NOT require you to fill your specialty pharmacy medications through the mail order specialty pharmacy that they own. #EmployeeBenefits #HealthInsurance #Healthcare

Stop assuming that having ₹1 crore health insurance is a foolproof plan. It’s time to rethink your coverage and ensure you're prepared for every unexpected health challenge. Make sure you get your health insurance plan reviewed by experts like Bajaj Capital Insurance Broking Ltd every 2 to 3 years. You may get a better cover at even a lower cost. Here’s what you don’t need: 1. A false sense of security thinking ₹1 crore is more than sufficient. 2. Overlooking the rising costs of advanced medical treatments. 3. Ignoring the importance of coverage flexibility for various illnesses. 4. Placing complete trust in a policy without understanding its limits. Here’s what you do need: → Combine a base policy with super top-ups and critical illness riders. → Periodically review your policy to keep pace with medical inflation, which has hovered at 14–16% per annum. → Evaluate and plan for ancillary expenses like diagnostics and home care. → Ensure your family is aware of your coverage details. Stop relying on a standalone policy to handle every medical expense. Stop underestimating medical inflation's impact on your coverage. Stop neglecting the need for a comprehensive insurance strategy. Your insurance plan should protect you, not just look impressive on paper. Are you adequately prepared for the real costs of healthcare?.. For a deeper dive into why it's crucial to rethink your insurance coverage and how to better protect your family, check out my article here: [Read the article](https://lnkd.in/gts2jV6u). #HealthInsurance #FinancialPlanning #MedicalInflation #InsuranceCoverage #HealthcareStrategy

Open claims do not flag when they lose a patient. That is what makes them risky. In closed claims, when a patient leaves, the data tells you. In open claims, when a patient leaves, the data may not tell you anything. ↳ The patient may still be there. ↳ The provider may still be seeing them. ↳ Care may still be happening. ↳ It just stops showing up in your dataset. 𝗛𝗼𝘄 𝗮 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗾𝘂𝗶𝗲𝘁𝗹𝘆 𝗱𝗶𝘀𝗮𝗽𝗽𝗲𝗮𝗿𝘀 𝗳𝗿𝗼𝗺 𝗼𝗽𝗲𝗻 𝗰𝗹𝗮𝗶𝗺𝘀 A patient sees four providers. Three of them route claims through clearinghouses that feed your dataset. The fourth, a cardiologist they started seeing last year, uses a different clearinghouse. In your data, the cardiologist visit never happened. The patient looks like someone who is not managing their cardiac condition. In reality, they may be on therapy, followed regularly, and clinically stable. Just with a provider your feed does not see. 𝗡𝗼𝘄 𝘀𝗰𝗮𝗹𝗲 𝘁𝗵𝗮𝘁 (𝗜𝗹𝗹𝘂𝘀𝘁𝗿𝗮𝘁𝗶𝘃𝗲) If say 20% of the prescribing specialists in a given area use a clearinghouse that does not contribute to your feed, your market share in that area looks 20% smaller than it actually is. Your sales team makes call planning decisions on that distorted view. If your persistence analysis is built on patients who appear continuously in open claims, you may be selecting for patients whose providers all happen to use the contributing clearinghouses. That is not the same as patients who actually persist on therapy. 𝗔𝗴𝗴𝗿𝗲𝗴𝗮𝘁𝗲 𝗰𝗼𝘃𝗲𝗿𝗮𝗴𝗲 𝘀𝘁𝗮𝘁𝘀 𝗵𝗶𝗱𝗲 𝗽𝗮𝘁𝗶𝗲𝗻𝘁-𝗹𝗲𝘃𝗲𝗹 𝗴𝗮𝗽𝘀 A dataset can be 70% nationally representative and still have blind spots by specialty, geography, site of care, or provider network. That is why open claims coverage should not be evaluated only at the total-record level. A few things help. → Stress test your dataset by specialty and region against external benchmarks before trusting market share at that cut. → Be cautious about persistence and journey analyses on patients with sparse activity. Sparse may mean dropped therapy, or it may mean the data lost them. → Compare open claims trends against external benchmarks where possible → Ask your data vendor which clearinghouses contribute to your feed and where the coverage is thinner, not just where coverage is strong 💡 𝗕𝗼𝘁𝘁𝗼𝗺 𝗹𝗶𝗻𝗲 Open claims do not flag when they lose a patient. The dataset stays full. The analysis keeps running. The risk is acting on numbers that look complete but are not. --- ♻️ Repost/Save if you find the information useful 🔔𝘐 𝘸𝘳𝘪𝘵𝘦 2-3 𝘢𝘳𝘵𝘪𝘤𝘭𝘦𝘴 𝘸𝘦𝘦𝘬𝘭𝘺 𝘢𝘣𝘰𝘶𝘵 𝘩𝘰𝘸 𝘩𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘴𝘺𝘴𝘵𝘦𝘮𝘴 𝘢𝘤𝘵𝘶𝘢𝘭𝘭𝘺 𝘸𝘰𝘳𝘬 𝘢𝘯𝘥 𝘸𝘩𝘦𝘳𝘦 𝘢𝘯𝘢𝘭𝘺𝘵𝘪𝘤𝘴 𝘤𝘩𝘢𝘯𝘨𝘦𝘴 𝘥𝘦𝘤𝘪𝘴𝘪𝘰𝘯𝘴. Follow me (Abhishek Singh)

A Cost–Benefit Analysis (CBA) in health insurance is the systematic process of comparing the costs of providing health insurance (or implementing a health insurance scheme) with the benefits it generates for individuals, insurers, and society. It helps policymakers, insurers, and stakeholders determine whether an insurance product or reform is worthwhile. Here’s a breakdown: 1. Costs in Insurance 📌Underwriting, claims management, marketing, IT systems, and regulatory compliance. 📌Reimbursements to hospitals, doctors, and other health providers. 📌Inefficiencies caused by moral hazard (excessive use of care) and adverse selection (high-risk individuals joining disproportionately). 2. Benefits of health Insurance 💡 Shielding individuals from catastrophic health expenditures or large losses. 💡Insured populations are more likely to seek timely care. 💡Spreading risks across many people lowers individual exposure. 💡Healthier populations are more productive economically. 💡Social health insurance can reduce inequalities in healthcare access. 3. Approaches to CBA in health Insurance ➡️ Assigning monetary values to both costs and benefits. Example: calculating the net present value (NPV) of a new health insurance scheme. ➡️ Considering non-monetary benefits like fairness, health system strengthening, and social stability. ➡️ Unlike cost-effectiveness (which focuses on outcomes per unit cost, e.g., cost per QALY gained), CBA tries to express all outcomes in monetary terms. 4. Applications in Health Insurance 🔄Deciding whether to introduce coverage for new services (like preventive care). 🔄 Evaluating reforms: e.g., Kenya’s Social Health Insurance Fund (SHIF) – balancing collection of premiums, government subsidies, and benefits to households. 🔄Assessing whether subsidizing premiums for the poor yields greater long-term social and economic returns than direct cash transfers. 5. Key Metrics 1️⃣ Net Present Value (NPV): NPV=Total Benefits – Total Costs 2️⃣ Benefit-Cost Ratio (BCR): BCR=Total Benefits/Total Costs. A ratio >1 indicates the insurance scheme is worthwhile. 3️⃣ Internal Rate of Return (IRR): discount rate at which NPV = 0, useful for long-term schemes. 6. Example in health Insurance: ✔️ Costs: $200 million in subsidies + $50 million in admin costs annually. ✔️ Benefits: $400 million in avoided catastrophic health expenditures, $100 million in productivity gains, and $50 million in long-term savings from preventive care. ✔️ Result: Benefits = $550 million; Costs = $250 million → BCR = 2.2 (economically justified).

🏥 New research just published: How do countries decide which medicines get covered? A comparative review in Pharmacoeconomics and Policy examined 10 Health Technology Assessment (HTA) agencies across the globe — and the differences are striking. 🔍 What was studied: NICE (England), SMC (Scotland), PBAC (Australia), CDA (Canada), IQWiG/G-BA (Germany), HAS (France), CONITEC (Brazil), ACE (Singapore), MaHTAS (Malaysia), and NHSA/NRDL (China) — compared across governance, methods, lifecycle integration, and stakeholder engagement. 📊 Key takeaways for policymakers: ⚖️ Independent agencies tend to have broader mandates; ministry-embedded units stay closer to reimbursement decisions 🔗 Binding coverage outcomes exist in England, France, Germany, and Brazil — but the legal pathways differ significantly 💰 Pricing negotiation is almost always tied to appraisal outputs 🔄 Lifecycle tools like horizon scanning and disinvestment remain underdeveloped in many systems 🤝 Structured stakeholder engagement varies widely — and mechanisms alone don't guarantee meaningful influence 🌍 The bottom line: There is no single model. But countries building or reforming HTA systems can draw real lessons from this comparison — especially on statutory grounding, analytical capacity, and transparent public engagement. For low- and middle-income countries, the evidence suggests starting focused (pharmaceuticals, high-budget technologies) and building incrementally from within existing institutions. David Bishai Lei Si Benjamin Yip Yingyao Chen Manuel Antonio Espinoza #HealthPolicy #HTA #HealthTechnology #UniversalHealthCoverage #Reimbursement #EvidenceBasedPolicy #GlobalHealth #Pharmacoeconomics

Family offices apply rigorous analysis to every investment decision. Then they treat health insurance like a commodity purchase. The disconnect costs them when claims get denied or coverage fails during critical moments. Apply investment-grade analysis to health coverage: • Create scoring systems for policy quality • Track claim approval rates by insurer • Measure coverage effectiveness across family members • Monitor policy performance annually • Document outcomes for continuous improvement Your family's health protection deserves the same analytical rigor as your portfolio management.

Using an independent third-party review for health plan claims is a smart strategy that benefits both the plan and its members. It provides unbiased oversight, ensuring claims are accurate and compliant with laws like ERISA and the No Surprises Act. This approach often uncovers overcharges, upcoding, and duplicate claims, saving plans an average of 30-40% on in network and 70% on out of network. By detecting fraud, waste, and abuse, third-party reviews protect plans from financial and legal risks while offering valuable insights into cost drivers and billing trends. They also enhance transparency by providing access to detailed claims data, eliminating the “black box” often seen with TPAs or carriers. Ultimately, this process ensures better decision-making, builds trust with members, and upholds fiduciary responsibilities. It’s a clear win for financial health, compliance, and member satisfaction. Do you believe your plan truly reviews your claims? 🦊🐓

The audit industry around self-funded health plans is shifting, just not in the way most think. Increased ERISA scrutiny has driven employer groups to take fiduciary oversight more seriously. That’s a good thing, but the how is where things can go sideways. Many Employer Groups are turning to third-party auditors who talk compliance but often create more noise than clarity. Many third-party auditors work without access to network contract terms or adjudication logic, which can result in inaccurate flags. Their contingency-based pricing models are designed to reward volume, even when accuracy or context is limited. The result? Claims are flagged without network context. False positives flood employer groups and brokers. TPAs and Health Plans are put on the defensive. And plans are left fielding questions they should never have had to answer. This reactive model isn’t scalable — and it’s not aligned with how responsible health plans operate. There’s a smarter path forward. -Preemptive screening: Identify integrity risks and pricing outliers before employer groups escalate. -Contract-aware logic: Apply real terms, not assumptions, to filter meaningful risk from noise. -Integrated resolution: Work collaboratively with TPAs instead of working around them. -Fixed, transparent pricing: Eliminate incentives that reward false alarms over actual insight. This model is already in use, helping health plans cut down audit friction, reduce vendor noise, and clearly show they’re meeting fiduciary obligations. In the visual below, we break down the exact shift happening and how forward-thinking Health Plans and TPA's are moving from audit defense to oversight leadership. We're seeing this shift play out in real time. What are you seeing? AMS (Advanced Medical Strategies)

📚 Handbook for Conducting Assessments of Barriers to Effective Health Coverage /WHO/2024 The World Health Organization (WHO) has launched a crucial resource for enhancing health service delivery and accessibility, especially in the context of equity-oriented reforms toward Universal Health Coverage (UHC). This comprehensive Handbook for Conducting Assessments of Barriers to Effective Coverage is designed to guide health authorities, researchers, and organizations in identifying and addressing the barriers that prevent equitable access to essential health services. Key Features: 📚 Structure: Eight modules applying mixed-method research approaches to assess barriers faced by both users and non-users of health services. 🔎 Framework: Utilizes the Tanahashi framework, focusing on barriers in: 🏥 Availability 🌍 Geographic accessibility 💰 Affordability 🤝 Acceptability 🎯 Target Audience: This handbook is aimed at national and subnational health authorities, research institutions, NGOs, and civil society organizations, fostering collaboration in identifying and addressing barriers to care. 💡 Focus on Equity: It emphasizes the need for strategies that leave no one behind, considering disadvantages like income, gender, and location. 🔧 Application: Provides methodologies to support evidence-based decision-making, monitor progress, and ensure policies are addressing barriers effectively. Why This Matters: Understanding barriers to effective coverage is essential for: 🏥 Improving health system performance ⚖️ Reducing health inequities 💸 Enhancing financial protection 👥 Ensuring patient-centered care #HealthEquity #UHC #GlobalHealth #WHO #HealthSystems #HealthPolicy #BarriersToCare #HealthForAll #EvidenceBasedPolicy #HealthReforms #UniversalHealthCoverage #InclusiveHealth #HealthAccessibility #PublicHealth #HealthcareEquity #PatientCenteredCare #SustainableHealthSystems #GlobalHealthDevelopment #HealthInnovation #HealthLeadership #SDG3 #HealthInclusion #TanahashiFramework

With employer healthcare costs projected to surge by 9.5% in 2026, the steepest climb in 15 years, many companies will simply absorb the financial blow. Strategic organizations, however, will use this as a catalyst to rethink their approach entirely. A recent Wall Street Journal report confirms what many CFOs and HR leaders are feeling. The increase is not a one-off event but a sustained trend driven by higher care prices, increased service use, and costly prescriptions. For mid-market companies lacking the negotiating power of giant enterprises, this presents a significant threat to financial stability and employee morale. Simply passing on these increases to employees or cutting benefits is a short-term fix with long-term consequences. Instead of reacting, leaders can take control with a more proactive strategy. This involves moving beyond a simple annual renewal and treating benefits as a core business function. Here are three levers that can be pulled right now: 1. Re-evaluate Funding Strategy: It may be time to explore alternative funding arrangements like self-insurance. As noted in the article, this gives companies more control over their plan design and can lead to significant cost savings by paying for employees’ actual medical costs directly, rather than paying fixed insurance premiums. 2. Aggressively Manage Pharmacy Benefits: Pharmacy expenses, especially for specialty drugs, are a primary driver of cost. A deep dive into your Pharmacy Benefit Manager (PBM) contract, formulary, and utilization patterns can uncover major opportunities for savings without compromising care. 3. Optimize Plan Design and Network: Steering employees toward high-quality, cost-effective providers is a powerful, yet underused, strategy. Implementing smarter plan designs that incentivize the use of efficient networks and care navigation tools can lower costs for both the company and its employees. Navigating this challenging environment requires a shift from a transactional to a consultative partnership. The companies that thrive will be those that build a sustainable, multi-year healthcare strategy, not just look for a quick fix for the next renewal cycle.